Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05215769 · ClinicalTrials.gov registry record · NA
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer
A NA study of Metastatic Malignant Solid Neoplasm and Stage IV Lung Cancer AJCC v8, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 243
- Enrollment target
- 4
- Study locations
NCT05215769 is a NA study of Metastatic Malignant Solid Neoplasm and Stage IV Lung Cancer AJCC v8 that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 243 participants, above the 204-participant average among 92 other Metastatic Malignant Solid Neoplasm trials with a reported enrollment target (19% higher). The trial reports 4 study locations across 1 state.
The verdict
NCT05215769, a NA study of Metastatic Malignant Solid Neoplasm and Stage IV Lung Cancer AJCC v8, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
- 4
- Study locations
Study Summary
This clinical trial tests whether a video intervention improves patient understanding of tumor genomic testing in patients with cancer that has spread to other parts of the body (metastatic). Measuring how the video intervention affects patient understanding of tumor genomic testing in patients with metastatic cancer may help doctors provide patient-centered care by effectively communicating the importance of tumor genomic testing.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- BEHAVIORAL Health Education
Study Locations (4)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
- St. Rita's - Lima
- Saint Francis Medical Center - Richmond
- Saint Elizabeth Youngstown Hospital - Youngstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2022-03-30 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05215769
The ClinicalTrials.gov registry entry for NCT05215769 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 204-participant average among 92 other Metastatic Malignant Solid Neoplasm trials with a reported enrollment target (19% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Metastatic Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT05215769 reports 4 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05215769 about?
NCT05215769 is a clinical study titled "A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer". This clinical trial tests whether a video intervention improves patient understanding of tumor genomic testing in patients with cancer that has spread to other parts of the body (metastatic). Measuring how the video intervention affects patient understanding of tumor genomic testing in patients with...
What is the current status of trial NCT05215769?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 243 participants. The study started on 2022-03-30. Estimated completion is 2026-07-31.
What conditions does trial NCT05215769 study?
This clinical trial studies the following conditions: Metastatic Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8.
What interventions are being tested in trial NCT05215769?
The interventions under investigation include: Questionnaire Administration (OTHER), Health Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05215769?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05215769 being conducted?
This trial has 4 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors
RECRUITING · NA
-
Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
RECRUITING · NA
-
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
RECRUITING · NA
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
RECRUITING · NA
-
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
RECRUITING · NA
-
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.